Cxcl16 overexpression in the APP/PS1 hippocampus is corroborated by the upregulation of its human orthologue in different brain areas of AD-affected patients and the positive correlation of Cxcl16 protein level with Aβ and tau pathology, in other AD animal models36. This evidence concerns the gene MAPT and Alzheimer disease.